Celgene's Blockbuster Disappoints Wall Street (BusinessWeek)
Sales of the drugmaker's blood cancer compound may have nearly doubled, but that wasn't enough for investors, who sold off the stock Thursday

KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets (The San Francisco Examiner)
ST. LOUIS , Oct. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has received approval from the U.S.

Abiomed Announces Results of Impella(R) 2.5 FDA PROTECT I Safety Trial for High-Risk PCI Cases (Business Wire via Yahoo! Finance)
DANVERS, Mass.----Abiomed, Inc. formally announced the results of its Impella 2.5 PROTECT I safety trial for the first time at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics Scientific Symposium and main sessions.